News
Magic mushroom decriminalization may have a fighting chance in DC after all.
Hi, what are you looking for?
Magic mushroom decriminalization may have a fighting chance in DC after all.
Are your psychedelic trips seeming a bit lackluster? Here are some possible explanations.
The psychedelic movement is striving to be more inclusive than it was in the 1960s.
Research into psychedelic mushrooms has yielded some key findings.
A firm devoted to psilocybin truffles is officially on the Canadian Stock Exchange.
America's attitudes towards psychedelics are shifting.
Will a psychedelics market follow that of cannabis?
Netflix’s new documentary aims to destigmatize the trippy taboo.
How an obscure band from Austin has had a monumental influence on music past and present.
Unfortunately, assault and other abuses of power seem to frequently occur in "healing" sessions.
Will yeast-derived psilocybin be the new big thing?
The pandemic isn't stopping psychedelic advocacy.
The placebo effect is not to be underestimated.
Petitions to decriminalize psychedelic mushrooms in Washington, DC have been temporarily halted.
Will the outbreak prevent activists from gathering signatures?
No, you weren’t the first one to take LSD and see God. Here’s some background.
The initiative would include all plants and fungi that naturally produce ibogaine, DMT, mescaline, psilocybin, or psilocin.
Representative Brian Cina is trying to move the state forward with relaxed laws on psychedelics.
MUSC's new psychedelic research center will be at the center of major developments in psychiatric medicine.
For the July, 1986 edition of High Times, Dean Latimer described what it's like to trip on ibogaine, a powerful psychedelic from Africa.